cancer clinical trials for Pediatric (PEDONC)

41 Pediatric (PEDONC) clinical trials found. View a list of all cancer clinical trial types.

• NCI-COG Pediatric Match (Molecular Analysis for Therapy Choice) Screening Protocol

  Current Status: Open

  View links and contact information related to this clinical trial

• NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Ensartinib in Patients with Tumors Harboring ALK or ROS1 Genomic Alterations

  Current Status: Open

  View links and contact information related to this clinical trial

• Project:EveryChild A Registry, Eligibility Screening, Biology and Outcome Study

  Current Status: Open

  View links and contact information related to this clinical trial

• ARST2031 A Randomized Phase 3 Trial of Vinorelbine, Dactinomycin, and Cyclophosphamide (VINO-AC) Plus Maintenance Chemotherapy with Vinorelbine and Oral Cyclophosphamide (VINO-CPO) vs Vincristine, Dactinomycin and Cyclophosphamide (VAC) plus VINO-CPO Maintenance in Patients with High Risk Rhabdomyosarcoma (HR-RMS)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL) (IND# 134379)

  Current Status: Open

  View links and contact information related to this clinical trial

• AREN03B2, Renal Tumors Classification, Biology, and Banking Study (Children's ID#477-0306) (IRB #240-06)

  Current Status: Open

  View links and contact information related to this clinical trial

• Quality of Life after Radiation Treatment in Pediatric Cancer Survivors

  Current Status: Open

  View links and contact information related to this clinical trial

• ANBL1232, Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma

  Current Status: Closed

  View links and contact information related to this clinical trial

• AALL1621. A Phase 2 Study of Inotuzumab Ozogamicin (NSC#772518, IND#133494) in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)

  Current Status: Open

  View links and contact information related to this clinical trial

• ACNS2031 A Phase 3 Study of Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children with Average-Risk Medulloblastoma and Reduced Therapy in Children with Medulloblastoma with Low-Risk Features

  Current Status: Open

  View links and contact information related to this clinical trial

• AALL1732, A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy

  Current Status: Open

  View links and contact information related to this clinical trial

• ACNS2021. A Phase 2 Trial of Chemotherapy followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor

  Current Status: Open

  View links and contact information related to this clinical trial

• The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  Current Status: Open

  View links and contact information related to this clinical trial

• AOST2031. A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma.

  Current Status: Open

  View links and contact information related to this clinical trial

• ACCL2031 A Phase 3 Randomized, Placebo-Controlled Trial Evaluating Memantine (IND# 149832) for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors

  Current Status: Open

  View links and contact information related to this clinical trial

• Prospective Cohort Study to Evaluate Immunologic Response Following COVID-19 Vaccination in Children, Adolescents and Young Adults with Cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

  Current Status: Open

  View links and contact information related to this clinical trial

• AOST2032. A Feasibility and Randomized Phase 2/3 Study of the VEFGR2/MET Inhibitor Cabozantinib in Combination with Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma.

  Current Status: Open

  View links and contact information related to this clinical trial

• ACNS1723. A Phase 2 Study of Dabrafenib (NSC# 763760) with Trametinib (NSC# 763093) after Local Irradiation in Newly-Diagnosed BRAFV600-Mutant High-Grade Glioma (HGG) (IND# 145355)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy

  Current Status: Open

  View links and contact information related to this clinical trial

• AGCT1532, Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours (P3BEP)

  Current Status: Open

  View links and contact information related to this clinical trial

• ANHL2121, A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

  Current Status: Open

  View links and contact information related to this clinical trial

• Umbrella Long-term Follow-up Protocol

  Current Status: Open

  View links and contact information related to this clinical trial

• A multicenter safety study of unlicensed, investigational cryopreserved cord blood units (CBUs) manufactured by the National Cord Blood Program (NCBP) and provided for unrelated hematopoietic stem cell transplantation of pediatric and adult patients

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma

  Current Status: Open

  View links and contact information related to this clinical trial

• AHEP1531 - Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)

  Current Status: Open

  View links and contact information related to this clinical trial

• ANHL1931. A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia

  Current Status: Open

  View links and contact information related to this clinical trial

• ACNS1931, A Phase 3 Study of Selumetinib (NSC# 748727, IND# 77782) or Selumetinib in Combination with Vinblastine for non-NF1, non-TSC Patients with Recurrent or Progressive Low-Grade Gliomas (LGGs) Lacking BRAFV600E or IDH1 Mutations

  Current Status: Open

  View links and contact information related to this clinical trial

• A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

  Current Status: Open

  View links and contact information related to this clinical trial

• ARST2032. A Prospective Phase 3 Study of Patients With Newly Diagnosed Very Low-Risk and Low-Risk Fusion Negative Rhabdomyosarcoma

  Current Status: Open

  View links and contact information related to this clinical trial

• A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  Current Status: Open

  View links and contact information related to this clinical trial

• ACNS1833 A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

  Current Status: Open

  View links and contact information related to this clinical trial

• AALL1821, A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

  Current Status: Open

  View links and contact information related to this clinical trial

• A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

  Current Status: Open

  View links and contact information related to this clinical trial

• AGCT1531. A Phase 3 study of active surveillance for low risk and a randomized trial of carboplatin vs.cisplatin for standard risk pediatric and adult patients with germ cell tumors.

  Current Status: Open

  View links and contact information related to this clinical trial

• AAML1831. A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized Web-Based Physical Activity Intervention Among Children and Adolescents With Acute Lymphoblastic Leukemia

  Current Status: Open

  View links and contact information related to this clinical trial

• ALTE22C1 Chronic Health Conditions in Down Syndrome-Associated Acute Leukemia: The Down Syndrome Phenotyping Acute Leukemia Study in Survivors (DS-PALS Survivors)

  Current Status: Open

  View links and contact information related to this clinical trial